NPPA Sets Deadline for Reports on Fixed-Dose Combinations

India’s drug pricing authority wants manufacturers of fixed-dose combination products that are less than four years old to confirm that the products have been approved and are not prohibited under the country’s drug laws.
International Pharmaceutical Regulatory Monitor